Search

Your search keyword '"Mohammed, Abdul Rasheed"' showing total 261 results

Search Constraints

Start Over You searched for: Author "Mohammed, Abdul Rasheed" Remove constraint Author: "Mohammed, Abdul Rasheed"
261 results on '"Mohammed, Abdul Rasheed"'

Search Results

101. Water-Drinking Test in Central Serous Chorioretinopathy

102. Prospective evaluation of changes in choroidal vascularity index after half-dose photodynamic therapy versus micropulse laser treatment in chronic central serous chorioretinopathy

104. Real Time Application of Vehicle Anti Theft Detection and Protection with Shock Using Facial Recognition and IoT Notification

105. En-face choroidal vascularity in central serous chorioretinopathy

106. Classification and Quantification of Retinal Cysts in OCT B-Scans: Efficacy of Machine Learning Methods

107. Analysis of Choroidal Vascularity Index in Keratoconus Patients Using Swept-Source Optical Coherence Tomography-Based Binarization Techniques

108. Optical coherence tomography angiography in acute unilateral nonarteritic anterior ischemic optic neuropathy: A comparison with the fellow eye and with eyes with papilledema

113. Discovery and Development of 3-(6-Chloropyridine-3-yloxymethyl)-2-azabicyclo[3.1.0]hexane Hydrochloride (SUVN-911): A Novel, Potent, Selective, and Orally Active Neuronal Nicotinic Acetylcholine α4β2 Receptor Antagonist for the Treatment of Depression

114. 1‐[2‐(1‐Cyclobutylpiperidin‐4‐yloxy)‐6,7‐dihydro‐4H‐thiazolo[5,4‐c]pyridin‐5‐yl]propan‐1‐one: a Histamine H3 Receptor Inverse Agonist with Efficacy in Animal Models of Cognition

115. En-face choroidal vascularity map of the macula in healthy eyes

116. New Insights on Choroidal Vascularity: A Comprehensive Topographic Approach

118. Choroidal Vascularity Map in Unilateral Central Serous Chorioretinopathy: A Comparison with Fellow and Healthy Eyes

119. Current Choroidal Imaging Findings in Central Serous Chorioretinopathy

120. Choroidal hyper-reflective foci and vascularity in retinal dystrophy

121. P3‐455: SUVN‐M8036, A SEROTONERGIC AND DOPAMINERGIC MODULATOR, ALLEVIATES PSYCHOSIS AND DEPRESSION

122. P1‐077: IN‐VITRO CHARACTERIZATION OF SUVN‐I2004: A NOVEL MUSCARINIC M 1 POSITIVE ALLOSTERIC MODULATOR

123. Wide-field Choroidal Vascularity in Healthy Eyes

124. Wide-field choroidal thickness profile in healthy eyes

126. 0053 SUVN-G3031: Safety, Tolerability and Pharmacokinetics of a Potent and Selective Histamine H3 Receptor Inverse Agonist - Single and Multiple Ascending Doses in Healthy Subjects

127. Discovery and Development of N-[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine H3 Receptor Inverse Agonist with Robust Wake-Promoting Activity

128. Choroidal Vascularity Index Using Swept-Source and Spectral-Domain Optical Coherence Tomography: A Comparative Study

129. [P1–460]: SUVN‐D4010: A POTENT AND SELECTIVE 5‐HT 4 RECEPTOR PARTIAL AGONIST— ASSESSMENT OF SAFETY, TOLERABILITY AND PHARMACOKINETICS IN HEALTHY HUMAN VOLUNTEERS

130. Diurnal variation in subfoveal and peripapillary choroidal vascularity index in healthy eyes

133. Synthesis, Structure–Activity Relationships, and Preclinical Evaluation of Heteroaromatic Amides and 1,3,4-Oxadiazole Derivatives as 5-HT4 Receptor Partial Agonists

134. P2‐062: Assessment of Central and Peripheral 5‐Ht 4 Receptor Occupancy in Rats

135. P3‐016: SUVN‐D4010, A Potent and Selective 5‐HT 4 Receptor Partial Agonist: Safety, Tolerability and Pharmacokinetics in Humans

136. Concise and Simple Synthesis of M1 Allosteric Agonist TBPB

137. Author Correction: Quantitative shadow compensated optical coherence tomography of choroidal vasculature

138. Automated quantification of Haller’s layer in choroid using swept-source optical coherence tomography

139. Qualitative comparison of choroidal vascularity measurement algorithms

140. Change in choroidal vascularity in acute central serous chorioretinopathy

141. Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer’s Disease

142. P2‐317: Suvn‐i1312004, a novel M1 muscarinic acetylcholine receptor‐positive allosteric modulator: Potential for the treatment of Alzheimer's disease

143. P1‐309: Suvn‐d4010: A novel 5‐ht 4 receptor partial agonist for the treatment of Alzheimer's disease

145. Discovery and Development of N‑[4-(1-Cyclobutylpiperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide Dihydrochloride (SUVN-G3031): A Novel, Potent, Selective, and Orally Active Histamine H3 Receptor Inverse Agonist with Robust...

146. Synthesis, characterization and ion transportation studies of some novel cyclophane amides

147. IN VIVO BRAIN RECEPTOR OCCUPANCY FOR PDE‐10 RECEPTORS IN MICE AND RATS USING NON‐RADIOLABELED TRACER

148. P1‐398: SUVN‐D4010: NOVEL 5‐HT4 RECEPTOR PARTIAL AGONIST FOR THE TREATMENT OF ALZHEIMER'S DISEASE

149. CATALYTIC OXIDATION OF THIOLS TO DISULFIDES WITH VANADYL ACETYLACETONATE (VO(ACAC)2)*

Catalog

Books, media, physical & digital resources